These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Irreversible enzyme inhibitors. CXXXIX. p-(4,6-Diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. VI. Further studies on effects of substitution on the propionamide bridge on isozyme specificity. Baker BR; Lourens GJ J Med Chem; 1969 Jan; 12(1):92-4. PubMed ID: 5763049 [No Abstract] [Full Text] [Related]
12. Irreversible enzyme inhibitors. CLX. Some factors in cell wall transport of active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines. Baker BR; Janson EE; Vermeulen NM J Med Chem; 1969 Sep; 12(5):898-902. PubMed ID: 5812208 [No Abstract] [Full Text] [Related]
13. Irreversible enzyme inhibitors. CLV. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[4-(omega-aminoalkoxy)-3-chlorophenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazines bearing a terminal sulfonyl fluoride. Baker BR; Janson EE J Med Chem; 1969 Jul; 12(4):672-6. PubMed ID: 5793160 [No Abstract] [Full Text] [Related]